GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Extracellular Vesicles Linked to Bone Marrow Alterations in Multiple Myeloma Progression

by GOAI
Share To

Recent research has examined the role of extracellular vesicles (EVs) in facilitating communication between malignant cells and their surrounding microenvironment, particularly in cases of multiple myeloma (MM). Studies have focused on how EVs contribute to interactions between cancerous cells and the bone marrow, a key site for MM progression. This research underscores the growing recognition of the importance of the tumor microenvironment in hematological malignancies.

Extracellular vesicles are small particles released by cells that carry molecular signals, including proteins and genetic material, which influence cellular behavior. In multiple myeloma, these vesicles appear to play a significant role in altering the bone marrow environment to support tumor growth and survival. Researchers are investigating how EVs mediate these changes and their potential impact on disease progression. The findings aim to deepen understanding of MM biology and may inform future therapeutic strategies targeting these cellular interactions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top